GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract W911QY20C0100MODERNATX, INC.

Overview

Award facts

Net obligations
$8.20B
$8,204,906,278of $8.20B potential value
Period of performance
Aug 11, 2020 to Aug 10, 2023
Ended
Modifications
32
Latest action Sep 22, 2023
Contract type
Definitive contract
PIID W911QY20C0100

Description of requirement

100M SARS-COV-2 MRNA-1273 VACCINE DOSES

Dates and value

Award date
Signed on Aug 11, 2020
Potential end of performance
Aug 9, 2023
Current value
$8,204,906,278Base and exercised options
Potential value (if all options are exercised)
$8,204,906,278

Obligations by fiscal year of action

  • FY2023: $287,655
  • FY2022: $59,026,961
  • FY2021: $6,920,591,663
  • FY2020: $1,225,000,000

Total across 4 fiscal years: $8,204,906,278

The Department of Defense funded and awarded this contract. DoD contract actions are withheld at the source for about 90 days after signature, so actions signed after Aug 20, 2026 are not yet public.

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 22, 2023. View on USAspending · Recipient on SAM.gov

Recipient

LocationCAMBRIDGE, MA
UEIWJYNZ8AK2D47
CAGE code6RP85
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyMODERNATX INC.

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Defense
  2. Department Of The Army
  3. W6QK ACC-APG NATICK
Funded by
  1. Department of Defense
  2. Department Of The Army
  3. W6DZ JPMO CBD JPMO MCS (06)
Funded from
Basic research; Field is optional prior to fy21Program activities021-2040Federal accounts (agency financial reports)

Place of performance

Place of performance
Cambridge, Middlesex County, Massachusetts 02139-3578
Congressional district (place of performance)
MA-07As reported at the time of the action

Classification and competition

Classification

Product or service (PSC)
6505DRUGS AND BIOLOGICALS (product)

Competition

Extent competed
Not competedC
Reason not competed
Urgency (FAR 6.302-2)URG
Solicitation procedures
Only one sourceSSS
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ
Offers received
1

Solicitation and notices

Solicitation ID
W911QY20R0043(as reported)
Solicitation date
Jul 1, 2020

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
Yes
Contract financing
Performance-based financingF
Service Contract Act labor standards
No
Commercial procedures
Commercial products/servicesA
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
Other undefinitized actionB
Multi-year contract
Yes

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Aug 11, 2020Base obligation at award: $1,225,000,000
Latest action
Sep 22, 2023 — Funding onlyModification P00031; obligation change -$220,345; funding only: changes obligations, not scope
Latest substantive action
May 1, 2023 — Supplemental agreement (within scope)Modification P00029; obligation change +$508,000
Latest funding action
Sep 22, 2023 — Funding onlyModification P00031; obligation change -$220,345; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Other administrative action22
  • Supplemental agreement (within scope)3
  • Option exercised3
  • Change order2
  • Funding only1
  • Change order definitized1
33 actions recorded, Aug 11, 2020 to Sep 22, 2023; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$220,345
Latest action: change in base and all options
-$220,345

Socio-economic and policy

Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Meets requirementsA
Clinger-Cohen Act planning (IT)
No
Walsh-Healey Act (materials and supplies)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Mfg in U.S.D
Sea transportation
No

Structure

Award or IDV
Award
Award type
Definitive contractD
IT commercial item category
Not IT products or servicesZ
DoD claimant program
Medical and dental supplies and equipmentC9B
Awarding agency code
9700
Awarding sub-tier code
2100
Contracting office code
W58P05
Transactions recorded under this award key
33

Funding

Funding agency code
9700
Funding sub-tier code
2100
Funding office code
W56XNH
Treasury accounts
  • 021-2020/2021-2040-000
  • 021-2021/2022-2040-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • N: Emergency P.L. 116-136
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
COVID-19 supplemental obligations
$2,450,000,000